Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-23 Option Award | 2024-01-25 4:27 pm | N/A 2034-01-23 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 255,000 | $0 | 255,000 (Direct) | View |
| 2023-02-13 Option Award | 2023-02-15 3:51 pm | N/A 2033-02-13 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 140,000 | $0 | 140,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-01-27 5:42 pm | N/A 2032-01-25 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 202,250 | $4.9432 | 202,250 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 4:37 pm | N/A 2031-05-03 | Cogent Biosciences Inc. | COGT | Kearns Evan Chief Legal Officer | 260,000 | $0 | 260,000 (Direct) | View |
| 2020-12-17 Option Award | 2020-12-21 1:42 pm | N/A 2030-12-17 | AGENUS INC | AGEN | Kearns Evan VP and General Counsel | 150,000 | $0 | 150,000 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-27 3:34 pm | N/A 2029-12-24 | AGENUS INC | AGEN | Kearns Evan See Remarks | 300,000 | $0 | 300,000 (Direct) | View |
| 2019-07-23 Option Award | 2019-07-25 6:46 pm | N/A 2029-07-23 | AGENUS INC | AGEN | Kearns Evan VP and General Counsel | 18,333 | $0 | 18,333 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 5:27 pm | N/A 2029-01-01 | AGENUS INC | AGEN | Kearns Evan V.P. and General Counsel | 200,000 | $0 | 200,000 (Direct) | View |